Skip to content
Study details
Enrolling now

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

University of Miami
NCT IDNCT06406855ClinicalTrials.gov data as of Apr 2026
Target enrollment

12

Study length

about 2.7 years

Ages

18–70

Locations

1 site in FL

About this study

This trial is testing a new therapy called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS) to see if it helps people with incomplete spinal cord injury walk better. The treatment will last for 968 days.

Based on ClinicalTrials.gov records.

What participants do

  • 1.BCI-TSCS
Primary goalNumber of treatment related incidence of adverse events (AEs)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low8%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Number of treatment related incidence of adverse events (AEs), Walking function using 6 minute walk test (6MWT)

Secondary: Quality of Life measured by the Reintegration to Normal Living (RNL) questionnaires, Quality of Life using the International Spinal Cord Injury - Quality of Life (ISCI-QOL)

Body systems

Neurology